Get the Stockscreener App
227.37
1.80%
-4.17
Pre-market:
227.00
-0.37
-0.16%
Penumbra Inc stock is traded at $227.37, with a volume of 575.95K.
It is down -1.80% in the last 24 hours and down -10.24% over the past month.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
See More
Previous Close:
$231.54
Open:
$230.92
24h Volume:
575.95K
Relative Volume:
1.38
Market Cap:
$8.87B
Revenue:
$1.24B
Net Income/Loss:
$42.23M
P/E Ratio:
214.50
EPS:
1.06
Net Cash Flow:
$150.33M
1W Performance:
-10.13%
1M Performance:
-10.24%
6M Performance:
-22.36%
1Y Performance:
-0.66%
1-Day Range:
$225.46
$231.66
1-Week Range:
$225.46
$260.00
52-Week Range:
$222.59
$310.00
Penumbra Inc Stock (PEN) Company Profile
Name
Penumbra Inc
Sector
Industry
Phone
(510) 995-2486
Address
ONE PENUMBRA PLACE, ALAMEDA, CA
Compare PEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
227.37 | 9.03B | 1.24B | 42.23M | 150.33M | 1.06 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-25 | Upgrade | Needham | Hold → Buy |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Mar-14-25 | Initiated | BofA Securities | Buy |
| Jan-21-25 | Initiated | UBS | Buy |
| Dec-17-24 | Initiated | Oppenheimer | Outperform |
| Dec-11-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-18-24 | Initiated | Stifel | Buy |
| Sep-03-24 | Initiated | Leerink Partners | Outperform |
| Jul-31-24 | Downgrade | Citigroup | Buy → Neutral |
| Jul-31-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-06-23 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Mar-29-23 | Downgrade | Needham | Buy → Hold |
| Jan-30-23 | Initiated | Piper Sandler | Overweight |
| Nov-04-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-09-22 | Upgrade | Needham | Hold → Buy |
| Jul-18-22 | Initiated | RBC Capital Mkts | Outperform |
| Apr-19-22 | Initiated | Deutsche Bank | Buy |
| Mar-08-22 | Initiated | Needham | Hold |
| Sep-16-21 | Initiated | Truist | Buy |
| Jun-04-21 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-16-20 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-07-20 | Resumed | Canaccord Genuity | Buy |
| Sep-29-20 | Initiated | BTIG Research | Buy |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | JP Morgan | Neutral → Overweight |
| May-21-19 | Initiated | William Blair | Outperform |
| Oct-29-18 | Resumed | BofA/Merrill | Buy |
| Oct-08-18 | Initiated | RBC Capital Mkts | Outperform |
| Feb-21-18 | Initiated | William Blair | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-13-15 | Initiated | Wells Fargo | Outperform |
View All
Penumbra Inc Stock (PEN) Latest News
Why Penumbra Inc. stock fits value portfoliosJuly 2025 Outlook & Weekly Return Optimization Alerts - newser.com
Is Penumbra Inc. stock a top hedge fund pickQuarterly Portfolio Report & Stepwise Trade Signal Implementation - newser.com
Does Penumbra Inc. stock trade at a discount to peersEarnings Risk Report & Verified Swing Trading Watchlists - newser.com
Strs Ohio Acquires New Position in Penumbra, Inc. $PEN - MarketBeat
Teacher Retirement System of Texas Buys 2,078 Shares of Penumbra, Inc. $PEN - MarketBeat
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Penumbra, Inc. $PEN - MarketBeat
Is Penumbra Inc. (0P8) stock a buy for dividend portfoliosJuly 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - newser.com
Wall Street Zen Downgrades Penumbra (NYSE:PEN) to Hold - MarketBeat
Penumbra Inc Stock Analysis and ForecastHealthcare Stock Analysis & Explosive Profit Growth - earlytimes.in
Penumbra, Inc. (PEN) Stock forecasts - Yahoo! Finance UK
Penumbra, Inc. (PEN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Earnings call transcript: Penumbra’s Q2 2025 performance shows strong growth - Investing.com Canada
Earnings call transcript: Penumbra’s Q2 2025 performance shows strong growth By Investing.com - Investing.com South Africa
Is Penumbra Inc. stock a contrarian opportunityJuly 2025 Volume & Fast Exit and Entry Strategy Plans - newser.com
Scholtz & Company LLC Raises Stock Holdings in Penumbra, Inc. $PEN - MarketBeat
Is Penumbra Inc. stock undervalued vs historical averages2025 Major Catalysts & Weekly Sector Rotation Insights - newser.com
Brighton Jones LLC Acquires Shares of 1,177 Penumbra, Inc. $PEN - MarketBeat
Penumbra Inc.’s STRIDE II Study: A Promising Update for Investors - MSN
Carret Asset Management LLC Sells 2,000 Shares of Penumbra, Inc. $PEN - MarketBeat
Will Penumbra Inc. stock attract ESG investorsTrade Ideas & Verified Technical Trade Signals - newser.com
Hantz Financial Services Inc. Lowers Position in Penumbra, Inc. $PEN - MarketBeat
Why Penumbra Inc. stock is a strong buy callMarket Growth Review & Consistent Profit Focused Trading Strategies - newser.com
Is Penumbra Inc. (0P8) stock a momentum leaderEarnings Growth Summary & Technical Buy Zone Confirmations - newser.com
How strong dollar benefits Penumbra Inc. stockMarket Sentiment Review & Growth Focused Stock Pick Reports - newser.com
Why Penumbra Inc. (0P8) stock is a strong buy call2025 Market Outlook & Long-Term Safe Return Strategies - newser.com
Penumbra, Inc. (PEN) Stock Forecasts - Yahoo Finance
Penumbra Inc. Launches i-RISE Study to Enhance Stroke Treatment Insights - TipRanks
Is Penumbra’s Stock Still a Good Bet After a 7% Drop in the Past Month? - Yahoo Finance
Custom watchlist performance reports with Penumbra Inc.Entry Point & Verified Short-Term Plans - newser.com
Ischemic Neurological Interventional Medical Devices Market - openPR.com
Penumbra Enters Oversold Territory (PEN) - Nasdaq
Why Penumbra (PEN) Shares Are Falling Today - Yahoo Finance
Truist Financial Sticks to Its Buy Rating for Penumbra (PEN) - The Globe and Mail
Penumbra’s thrombectomy system shows superior results for PE patients By Investing.com - Investing.com Australia
Y Intercept Hong Kong Ltd Takes $5.60 Million Position in Penumbra, Inc. $PEN - MarketBeat
MQS Management LLC Buys Shares of 1,030 Penumbra, Inc. $PEN - MarketBeat
What earnings margins imply for Penumbra Inc. (0P8) stock2025 Investor Takeaways & Expert Approved Momentum Trade Ideas - fcp.pa.gov.br
Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism - Lelezard
Penumbra Inc Stock (PEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
14.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):